These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anticancer chemotherapy. Davey P; Tudhope GR Br Med J (Clin Res Ed); 1983 Jul; 287(6385):110-3. PubMed ID: 6407699 [No Abstract] [Full Text] [Related]
4. [General principles and new trends of cytostatic tumor therapy]. Holfeld H; Bamberg M Strahlentherapie; 1980 May; 156(5):297-307. PubMed ID: 7190333 [No Abstract] [Full Text] [Related]
5. Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute. Carter SK; Slavik M Natl Cancer Inst Monogr; 1977 Mar; (45):101-21. PubMed ID: 73134 [No Abstract] [Full Text] [Related]
6. [New antineoplastic agents, their value and use]. Pawlicki M; Zuchowska-Vogelgesang B Przegl Lek; 1982 Sep; 39(8):561-5. PubMed ID: 6182581 [No Abstract] [Full Text] [Related]
7. Investigational drugs under study by the United States National Cancer Institute. Carter SK; Slavik M Cancer Treat Rev; 1976 Mar; 3(1):43-60. PubMed ID: 62615 [No Abstract] [Full Text] [Related]
8. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung. Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467 [No Abstract] [Full Text] [Related]
9. Advanced inoperable stomach cancer: a pilot study with the combination etoposide, adriamycin and cisplatin. Preusser P; Wilke H; Achterrath W; Neuhaus B; Balleisen L; Meyer J; Van de Loo J Anticancer Res; 1986; 6(5):1195-6. PubMed ID: 3800325 [TBL] [Abstract][Full Text] [Related]
10. [Foundations of the therapy of inoperable malignomas and hemoblastoses]. Stacher A Wien Med Wochenschr; 1976 Jan; 126(5):51-4. PubMed ID: 948909 [No Abstract] [Full Text] [Related]
11. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin. Jain N; Lam YM; Pym J; Campling BG Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677 [TBL] [Abstract][Full Text] [Related]
13. [Medical treatment of soft-tissue sarcomas in adults]. Lucas P; Spielmann M Bull Cancer; 1985; 72(3):183-201. PubMed ID: 3907733 [TBL] [Abstract][Full Text] [Related]
14. New drugs for the treatment of sarcomas. van Oosterom AT; Verweij J Hematol Oncol Clin North Am; 1995 Aug; 9(4):909-25. PubMed ID: 7490248 [TBL] [Abstract][Full Text] [Related]
15. [Research project of cancer chemotherapy]. Ogawa M Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):595-600. PubMed ID: 3920968 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of melanoma. Luce JK Semin Oncol; 1975 Jun; 2(2):179-85. PubMed ID: 1234375 [No Abstract] [Full Text] [Related]
17. Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review. Sørensen JB; Clerici M; Hansen HH Cancer Chemother Pharmacol; 1988; 21(2):89-102. PubMed ID: 3280154 [TBL] [Abstract][Full Text] [Related]
18. Antineoplastic chemotherapy. Mutz ID; Vietti TJ South Med J; 1977 Jul; 70(7):847-54. PubMed ID: 327567 [No Abstract] [Full Text] [Related]
19. Biochemical aspects of drug combinations. Brockman RW Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108 [No Abstract] [Full Text] [Related]
20. [Anticancer chemotherapy. Prescription in the presence of renal insufficiency]. Moulin B; Fillastre JP; Godin M; Chantrel F Nephrologie; 1995; 16(3):233-8. PubMed ID: 7783831 [No Abstract] [Full Text] [Related] [Next] [New Search]